Jol-van der Zijde, C.M.

rabie response antibody vaccination immunization anti-rabie vaccine patient booster fi ve patients booster vaccination 4 weeks igg 1 immunode ficiency rabies vaccine avidity immunode ficiency neoantigen study humoral adult individual t-cell rabies vaccination igg subclasses virus proliferative response booster immunization immunol antigen avidity maturation titer proliferative proliferation signi serum concentration index immunology ### neoantigen rabies fi rst vaccination subclasse result *** iu /ml 1012-joci december range journal increase joci.cl reference time-point rabies virus volunteer stimulation t test 37◦ c diploid avidity index culture /well plate antibody avidity igg 3 fidence interval month person effect igg anti-rabies antibodies signi ficant increase elisa speci level nonspeci fic binding maturation group igg antibody titer